Dashboard

View record

Title Biomarker Discovery In Seronegative Neuromyelitis Optica (NMO)

File number 33/16/2019-TF/Rare/BMS

Funding agency ICMR

Start date Jan. 11, 2021

End Date Jan. 10, 2024

Duration Three Year

Disease category Seronegative Neuromyelitis Optica

Type of study None

Type of data None

Aims of objective To determine the frequency of anti AQP-4 and anti MOG antibodies in clinically suspected cases of NMO in India and compare clinical imaging and response to therapy between the two groups and seronegat

Keyword Neuromyelitis optica spectrum disorder, Seronegative NMO, biomarker, proteomics, DIA, protein struct

Description None

Total Sanctioned budget 72,50,877/-

Principle Investigator Dr. Anita Mahadevan/None/Dept. of Neuropathology , NIMHANS, Bangalore

CoPrincipal Investigator Dr. T.S.Keshava Prasad/None/Center for systmes biology and molecular medicine , Yenopoya research , Mangalore